Biofrontera Inc. 10-Q

Item 5. Other Information None. Item 6. Exhibits (a) The following exhibits are included as part of this report: Exhibit Number Description of Document 3.1 Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-40943) filed with the SEC on November 3, 2021). 3.2 Amended and Restated Bylaws of the Company (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 001-40943) filed with the SEC on November 3, 2021). 31.1* Rule 13a-14(a)/15d-14(a) Certification of Erica L. Monaco. 31.2* Rule 13a-14(a)/15d-14(a) Certification of Erica Gates. 32.1* Certification pursuant to 18 U.S.C. Section 1350 by Chief Executive Officer. 32.2* Certification pursuant to 18 U.S.C. Section 1350 by Corporate Controller. 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. 101.SCH Inline XBRL Taxonomy Extension Scheme Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Labe Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) * Filed or furnished herewith 35 Signatures In accordance with the requiremen ts of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BIOFRONTERA INC. Dated: November 30, 2021 By: /s/ Erica L. Monaco Erica L. Monaco Chief Executive Officer (Principal Executive Officer) Dated: November 30, 2021 By: /s/ Erica Gates Erica Gates, CPA Corporate Controller (Chief Accounting Officer) 36